Heinzlef O, Cohen A, Amarenco P
Department of Neurology, Saint-Antoine Hospital, Paris, France.
Curr Opin Neurol. 1997 Feb;10(1):64-72. doi: 10.1097/00019052-199702000-00013.
In the past few years evidence that atherosclerotic disease of the aortic arch is probably an underestimate source of emboli, particularly moving thrombi in the lumen, has accumulated. Pathological studies, and more recently transesophageal echocardiographic studies, have shown that atherosclerotic disease of the aortic arch is an independent risk factor for ischemic stroke and carries a high risk of recurrent vascular events. It could account for a more or less part of brain infarcts of unknown cause, with no carotid or cardiac source of emboli. This location of atherosclerotic disease is rare under 60 years of age. It mainly involves patients older than 60 years of age, and is frequent in patients in their eighties. Transesophageal echocardiography is accurate, safe and well tolerated for the examination of the aortic arch, even in elderly patients. Practical implications for patients and future clinical trials are important. As it is a strong marker for recurrent vascular events, the risks and benefits of different therapeutic options should now be evaluated in randomised trials.
在过去几年中,越来越多的证据表明,主动脉弓动脉粥样硬化疾病可能是栓子的一个被低估的来源,尤其是管腔内移动的血栓。病理研究以及最近的经食管超声心动图研究表明,主动脉弓动脉粥样硬化疾病是缺血性卒中的独立危险因素,并且具有较高的复发性血管事件风险。它可能或多或少地占不明原因脑梗死的一部分,且不存在颈动脉或心脏栓子来源。这种部位的动脉粥样硬化疾病在60岁以下人群中很少见。它主要累及60岁以上的患者,在80多岁的患者中很常见。经食管超声心动图对主动脉弓的检查准确、安全且耐受性良好,即使在老年患者中也是如此。对患者的实际影响以及未来的临床试验都很重要。由于它是复发性血管事件的一个强有力指标,现在应该在随机试验中评估不同治疗方案的风险和益处。